0001209191-21-032968.txt : 20210514 0001209191-21-032968.hdr.sgml : 20210514 20210514200719 ACCESSION NUMBER: 0001209191-21-032968 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210504 FILED AS OF DATE: 20210514 DATE AS OF CHANGE: 20210514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAILES JOSEPH S CENTRAL INDEX KEY: 0001201039 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38800 FILM NUMBER: 21927002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Harpoon Therapeutics, Inc. CENTRAL INDEX KEY: 0001708493 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473458693 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BOULEVARD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-443-7400 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BOULEVARD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-05-04 2021-05-07 0 0001708493 Harpoon Therapeutics, Inc. HARP 0001201039 BAILES JOSEPH S C/O HARPOON THERAPEUTICS, INC. 131 OYSTER POINT BOULEVARD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Director Stock Option (Right to Buy) 23.20 2021-05-04 4 A 0 10167 0.00 A 2031-05-03 Common Stock 10167 10167 D This option was erroneously reported with a price of $22.50 on the original Form 4 filed on May 7, 2021 due to an administrative error. The stock option will fully vest and become exercisable on May 3, 2022, subject to the continuous service of the Reporting Person with the Issuer on such date. The original Form 4 filed on May 7, 2021 erroneously reported this vesting date as May 4, 2022. /s/ Joseph S. Bailes by Christopher Whitmore, Attorney-in-Fact 2021-05-14